Nuveen’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Nuveen’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-144,888	Closed	-$6.96M	–	3456
2020 Q1	$6.96M	Buy	144,888 +7,383	+5%	+$343K	﹤0.01%	1517
2019 Q4	$6.45M	Sell	137,505 -22,778	-14%	-$1.01M	﹤0.01%	1849
2019 Q3	$3.79M	Sell	160,283 -58,427	-27%	-$1.73M	﹤0.01%	2109
2019 Q2	$6.58M	Buy	+218,710	New	+$5.01M	﹤0.01%	1843

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Nuveen's RARX Position: Q2 2020 in Review

Nuveen sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 144,888 shares — an estimated $6.96M sold.

Nuveen first reported a position in RARX in Q2 2019 and held it in 4 quarters. The position peaked at $6.96M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Nuveen reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Nuveen sold 144,888 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $6.96M.
Nuveen first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Nuveen's Ra Pharmaceuticals, Inc. Common Stock position peaked at $6.96M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.